ICER expression inhibits leukemia phenotype and controls tumor progression

Leukemia

Volumn 22, Issue 12, 2008, Pages 2217-2225

  Pigazzi, M ^a   Manara, E ^a   Baron, E ^a   Basso, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INDUCIBLE CYCLIC AMP EARLY REPRESSOR PROTEIN; PROTEASOME; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CELL STRAIN HL 60; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MOUSE; MYELOPOIESIS; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION;

EID: 57849120060     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.244     Document Type: Article

References (50)

1. Molina CA, Foulkes NS, Lalli'E, Sassone-Corsi P. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor. Cell 1993; 75 875-886.
2. Razavi R, Ramos JC, Yehia G, Schlotter F, Molina CA. ICER-IIg is a tumor suppressor that mediates the anti proliferative activity of cAMP. Oncogene 1998; 17: 3015-3019.
3. Folco EJ, Koren G. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem J 1997; 328 37-43.
4. Haus-Seuffert P, Meisterernst M. Mechanism of transcriptional activation of cAMP-responsive element binding protein CREB. Mol Cell Biochem 2005; 212: 5-9.
5. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2: 599-609.
6. Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A et al. The role of CREB as proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 2005; 7: 351-362.
7. Jaworski J, Mioduszewska B, Sanchez-Capelo A, Figiel I, Habas A, Gozdz A et al. Inducible cAMP early repressor, an endogenous antagonist of cAMP responsive element-binding protein, evokes neuronal apoptosis in vitro. J Neurosci 2003; 23: 4519-4526.
8. Yan C, Ding B, Shishido T, Itoh S, Jeon KI, Liu W et al. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/ inducible cAMP early repressor feedback loop. Circ Res 2007; 100: 510-519.
9. Servillo G, Viola Magni M, Sassone-Corsi P. Coupling cAMP signaling to transcription in the liver: Pivotal role of CREB and CREM. Exp Cell Res 2002; 275: 143-154.
10. Memin E, Yehia G, Razavi R, Molina CA. ICER reverses tumorigenesis of rat prostate tumor cells without affecting cell growth. Prostate 2002; 53: 225-231.
11. Peri A, Conforti B, Baglioni-Peri S, Luciani P, Cioppi F, Bud L et al Expression of cyclic adenosine 3′,5′-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gs alpha gene. J Clin Endocrinol Metab 2001; 86: 2111-2117.
12. Pigazzi M, Ricotti E, Germano G, Faggian D, Aricò M, Basso G. cAMP response element binding protein (CREB) overexpression in childhood acute lymphoblastic and myeloid leukemia. Haematologica 2007; 92: 1435-1437.
13. Cheng JC, Esparza S, Sandoval S, Shankar D, Fu C, Sakamoto KM. Potential role od CREB as a prognostic marker in acute myeloid leukemia. Future Oncol 2007; 3: 475-480.
14. Schwaninger M, Blume R, Oetjen E, Lux G, Knepel WS. Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J Biol Chem 1993; 268: 5168-5177.
15. Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V et al. Vegfr-1 (flt-1), β1 integrin and herg k+ channel form a macromolecular signaling complex in acute myeloid leukemia: Role in cell migration and clinical outcome. Blood 2007; 110: 1230-1250.
16. Steg A, Wang W, Blanquicett C, Grunda JM, Eltoum IA, Wang K et al. Multiple gene expression analyses in paraffin-ambedded tissues by taqman low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn 2006; 8: 76-83.
17. Langmann T, Mauerer R, Schmitz G. Human ATP-Binding cassette transporter TaqMan low density array: Analysis of macrophage differentiation and foam cell formation. Clin Chem 2006; 52: 310-313.
18. -ΔΔCT metho. Methods 2001; 25: 402-408.
19. Cheng JC, Kinio K, Judelson DR, Chang J, Wu WS, Schmid U et al. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood 2008; 111: 1182-1192.
20. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J et al Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005; 102: 4459-4464.
21. Arakawa K, Kono N, Yamada Y, Mori H, Tomita M. KEGG-based pathway visualization tool for complex omics data. In Silico Biol 2005; 5: 419-423.
22. Cammenga J, Niebuhr B, Horn S, Bergholz U, Putz G, Buchholz F et al RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation. Cancer Res 2007; 67: 537-545.
23. Harhaj NS, Sun SC, Harhaj EW. Activation of NF-kappa B by the human T cell leukemia virus type I Tax oncoprotein is associated with ubiquitin-dependent relocalization of I kappa B kinase. J Biol Chem 2007; 282: 4185-4192.
24. Milella M, Konopleva M, Precupanu CM, Tabe Y, Ricciardi MR, Gregorj C et al. MEK blockade converts AML differentiating response to retinoids into extensive apoptosis. Blood 2007; 109: 2121-2129.
25. Berman JN, Look AT. Targeting transcription factors in acute leukemia in children. Curr Drug Targets 2007; 8: 727-737.
26. Koldehoff M, Steckel NK, Beelen DW, Elmaagacli AH. Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia. Clin Exp Med 2007; 7: 47-55.
27. Dasmahapatra G, Yerram N, Dai Y, Dent P, Grant S. Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation. Clin Cancer Res 2007; 13: 4280-4290.
28. Manna PR, Dyson MT, Eubank DW, Clark BJ, Lalli E, Sassone-Corsi P et al. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol Endocrinol 2002; 16: 184-199.
29. Peri A, Luciani P, Tonacchera M, Agretti P, Baglioni-Peri S, Buci L et al. Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas. J Clin Endocrinol Metab 2002; 146: 759-766.
30. Steigedal TS, Bruland T, Misund K, Thommesen L, Laegreid A. Inducible cAMP early repressor suppresses gastrin-mediated activation of cyclin D1 and c-Fos gene expression. Am J Physiol Gastrointest Liver Physiol 2007; 292: 1062-1069.
31. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT et al. The PKA/ CREB pathway is closely involved in VEGF expression in mouse macrophages. Mol Cells 2007; 23: 23-29.
32. Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Lovato P, Labuda T, Erksen KW et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia 2006; 20: 1759-1766.
33. Wang M, Zhang W, Crisostomo P, Markel T, Meldrum KK, Fu XY et al. STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J Mol Cell Cardiol 2007; 42: 1009-1015.
34. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 2007; 13: 3423-3430.
35. Chang JH, Vuppalanchi D, van Niekerk E, Trepel JB, Schanen NC, Twiss JL. PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control cAMP response element-dependent transcription in response to nerve growth factor and cAMP. J Neurochem 2006; 99: 1517-1530.
36. Misund K, Steigedal TS, Laegreid A, Thommesen L. Inducible cAMP early repressor splice variants ICER I and IIgamma both repress transcription of c-fos and chromogranin A. J Cell Biochem 2007; 101: 1532-1544.
37. Abderrahmani A, Cheviet S, Ferdaoussi M, Coppola T, Waeber G, Regazzi R. ICER induced by hyperglycemia represses the expression of genes essential for insulin exocytosis. EMBO J 2006; 25: 977-986.
38. Xu Y, Fang F, St Clair DK, Josson S, Sompol P, Spasojevic I et al. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1 {alpha},25-dihydroxyvitamin D3 in prostate cancer cells. Mol Cancer Ther 2007; 6: 2048-2056.
39. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F et al Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 2007; 9: 470-478.
40. Plaza-Menacho I, van der Sluis T, Hollema H, Gimm O, Buys CH, Magee AI et al. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation. J Biol Chem 2007; 282: 6415-6424.
41. Nandi A, Rapoport A. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF. Leukemia Research 2007; 30: 437-447.
42. Esparza S, Chang J, Shankar DB, Zhang B, Nelson SF, Sakamoto KM. CREB regulates Meis1 expression in normal and malignant hematopoietic cells. Leukemia 2008; 22: 665-667.
43. Tucker SJ, Rae C, Littlejohn AF, Paul A, MacEvan DJ. Switching leukaemia cell phenotype between life and death. PNAS 2004; 101: 12940-12945.
44. Zhou H, Gao J, Lu ZY, Lu L, Dai W, Xu M. Role of c-Fos/JunD in protecting stress-induced cell death. Cell Prolif 2007; 40: 431-444.
45. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002; 12: 9-18.
46. Morales V, Gonzalez-Robayna I, Santana MP, Hernandez I, Fanjul LF. Tumor necrosis factor-alpha activates transcription of inducible repressor form of 3′,5′-cyclic adenosine 5′-monophosphate-responsive element binding modulator and represses P450 aromatase and inhibin alpha-subunit expression in rat ovarian granulosa cells by a p44/42 mitogen-activated protein kinase-dependent mechanism. Endocrinology 2006; 147: 5932-5939.
47. Yan C, Clint LM, Jun-ichi A. Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the hearth. Circ Res 2007; 100: 489-501.
48. Hu Y, Lund IV, Gravielle MC, Farb DH, Brooks-Kayal AR, Russek SJ. Surface expression of GABA(A) receptors is transcriptionally conmtrolled by the interplay of CREB and its binding partner ICER. J Biol Chem 2008; 283: 9328-9340.
49. Mouravlev A, Young D, During MJ. Phosphorylation-dependent degradation of transgenic CREB protein initiated by heterodimerization. Brain Res 2007; 1130: 31-37.
50. Siu YT, Jin DY. CREB- a real culprit in oncogenesis. FEBS J 2007; 274: 3224-3232.